PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Market Analysis and Trades for 6/11

PharmD_KS's avatar
PharmD_KS
Jun 10, 2026
∙ Paid

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so the Discord option includes Substack content but a new Substack subscription does not include Discord access.

Be sure you have read the Starter Kit, including the free section even if you’re a paid subscriber. Trading Doggy Style Starter Kit

The weekly post for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. It can be found here Market Analysis for the Week of 6/7

I was a bit skeptical of yesterday’s rally into the close, and we saw that manifest a bit today:

On NQ we saw the reactive bid come in on the dip below 28663 overnight. At the case open we got a quick LBAF of 28800-28817 for a couple of nice trade opportunities on the long side. The fun for bulls was over, however, on the LAAF the IB high. Bulls tried to defend 663 multiple times but it ultimately flipped to resistance into the close.

ES was weaker overnight and 7345-7350 was cleanly lost and flipped to resistance. This led to a move to the demand in the 7290-7310 range about which I was skeptical (overnight low 7305.5).

It held overnight, 7345-7350 was reclaimed, and the open saw a quick LBAF of 7345-7350 which triggered a long to 7406-7415. A short of 7406-7415 was the top rated setup and put in high of day.

Once 7345-7350 flipped to resistance bulls were in trouble the rest of the day.

Sellers remain in control of short time frames. In tonight’s plan we’ll discuss what buyers would need to do to negate this, along with additional downside targets should sellers continue to press.

Paid Content Below or in the Discord

JOIN THE DISCORD

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 PharmD_KS · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture